Therapeutic polypeptides based on HBcAg18-27 CTL epitope can induce antigen-specific CD8+ CTL-mediated cytotoxicity in HLA-A2 transgenic mice

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 10, Issue 8

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

401

HTML

2061

Figures (1-1)

146

Tables (1-2)

156

Sum=2764

Apr 15, 2004 (publication date) through Jul 22, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Apr 15, 2004; 10(8): 1222-1226
Published online Apr 15, 2004. doi: 10.3748/wjg.v10.i8.1222

Table 1 TH1 polarization assay with an IFN-γ ELISPOT method. (mean ± SD, n = 18)

	Peptide1	Peptide2	Peptide3	MART-1_27-35	Negative controls
ISC/10⁶ lymphocytes	1 150 ± 236.7^d	1 367 ± 231^d	8 050 ± 1 233.8^d^b	1 135 ± 312	250 ± 138

^dP < 0.01 vs negative control;

^bP < 0.01 vs peptide1 and 2 groups.

Citation: Shi TD, Wu YZ, Jia ZC, Zhou W, Zou LY. Therapeutic polypeptides based on HBcAg_18-27 CTL epitope can induce antigen-specific CD₈⁺ CTL-mediated cytotoxicity in HLA-A2 transgenic mice. World J Gastroenterol 2004; 10(8): 1222-1226
URL: https://www.wjgnet.com/1007-9327/full/v10/i8/1222.htm
DOI: https://dx.doi.org/10.3748/wjg.v10.i8.1222